IBDEI1N6 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29523,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,29524,0)
 ;;=331.0^^186^1874^11
 ;;^UTILITY(U,$J,358.3,29524,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29524,1,4,0)
 ;;=4^Alzheimer's Disease
 ;;^UTILITY(U,$J,358.3,29524,1,5,0)
 ;;=5^331.0
 ;;^UTILITY(U,$J,358.3,29524,2)
 ;;=^5679
 ;;^UTILITY(U,$J,358.3,29525,0)
 ;;=250.01^^186^1874^5
 ;;^UTILITY(U,$J,358.3,29525,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29525,1,4,0)
 ;;=4^Diabetes Type 1
 ;;^UTILITY(U,$J,358.3,29525,1,5,0)
 ;;=5^250.01
 ;;^UTILITY(U,$J,358.3,29525,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,29526,0)
 ;;=250.00^^186^1874^4
 ;;^UTILITY(U,$J,358.3,29526,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29526,1,4,0)
 ;;=4^Diabetes Type 2
 ;;^UTILITY(U,$J,358.3,29526,1,5,0)
 ;;=5^250.00
 ;;^UTILITY(U,$J,358.3,29526,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,29527,0)
 ;;=577.0^^186^1874^18
 ;;^UTILITY(U,$J,358.3,29527,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29527,1,4,0)
 ;;=4^Pancreatitis,Acute
 ;;^UTILITY(U,$J,358.3,29527,1,5,0)
 ;;=5^577.0
 ;;^UTILITY(U,$J,358.3,29527,2)
 ;;=^2643
 ;;^UTILITY(U,$J,358.3,29528,0)
 ;;=785.4^^186^1874^34
 ;;^UTILITY(U,$J,358.3,29528,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29528,1,4,0)
 ;;=4^Gangrene
 ;;^UTILITY(U,$J,358.3,29528,1,5,0)
 ;;=5^785.4
 ;;^UTILITY(U,$J,358.3,29528,2)
 ;;=^49194
 ;;^UTILITY(U,$J,358.3,29529,0)
 ;;=780.99^^186^1874^32
 ;;^UTILITY(U,$J,358.3,29529,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29529,1,4,0)
 ;;=4^Chills
 ;;^UTILITY(U,$J,358.3,29529,1,5,0)
 ;;=5^780.99
 ;;^UTILITY(U,$J,358.3,29529,2)
 ;;=Chills^1
 ;;^UTILITY(U,$J,358.3,29530,0)
 ;;=991.3^^186^1874^66
 ;;^UTILITY(U,$J,358.3,29530,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29530,1,4,0)
 ;;=4^Frostbite NEC/NOS
 ;;^UTILITY(U,$J,358.3,29530,1,5,0)
 ;;=5^991.3
 ;;^UTILITY(U,$J,358.3,29530,2)
 ;;=^48340
 ;;^UTILITY(U,$J,358.3,29531,0)
 ;;=991.2^^186^1874^65
 ;;^UTILITY(U,$J,358.3,29531,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29531,1,4,0)
 ;;=4^Frostbite Of Foot
 ;;^UTILITY(U,$J,358.3,29531,1,5,0)
 ;;=5^991.2
 ;;^UTILITY(U,$J,358.3,29531,2)
 ;;=^276237
 ;;^UTILITY(U,$J,358.3,29532,0)
 ;;=991.1^^186^1874^64
 ;;^UTILITY(U,$J,358.3,29532,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29532,1,4,0)
 ;;=4^Frostbite Of Hand
 ;;^UTILITY(U,$J,358.3,29532,1,5,0)
 ;;=5^991.1
 ;;^UTILITY(U,$J,358.3,29532,2)
 ;;=^276235
 ;;^UTILITY(U,$J,358.3,29533,0)
 ;;=991.4^^186^1874^67
 ;;^UTILITY(U,$J,358.3,29533,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29533,1,4,0)
 ;;=4^Immersion Foot
 ;;^UTILITY(U,$J,358.3,29533,1,5,0)
 ;;=5^991.4
 ;;^UTILITY(U,$J,358.3,29533,2)
 ;;=^61358
 ;;^UTILITY(U,$J,358.3,29534,0)
 ;;=V70.5^^186^1874^68
 ;;^UTILITY(U,$J,358.3,29534,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29534,1,4,0)
 ;;=4^Health Exam-Group Survey
 ;;^UTILITY(U,$J,358.3,29534,1,5,0)
 ;;=5^V70.5
 ;;^UTILITY(U,$J,358.3,29534,2)
 ;;=^295595
 ;;^UTILITY(U,$J,358.3,29535,0)
 ;;=585.4^^186^1874^19
 ;;^UTILITY(U,$J,358.3,29535,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29535,1,4,0)
 ;;=4^Chr Kidney Dis Stage IV
 ;;^UTILITY(U,$J,358.3,29535,1,5,0)
 ;;=5^585.4
 ;;^UTILITY(U,$J,358.3,29535,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,29536,0)
 ;;=202.80^^186^1874^3
 ;;^UTILITY(U,$J,358.3,29536,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29536,1,4,0)
 ;;=4^Lymphoma Nec Unspec Site
 ;;^UTILITY(U,$J,358.3,29536,1,5,0)
 ;;=5^202.80
 ;;^UTILITY(U,$J,358.3,29536,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,29537,0)
 ;;=782.2^^186^1874^33
 ;;^UTILITY(U,$J,358.3,29537,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29537,1,4,0)
 ;;=4^Local Suprficial Swellng
